Reported interim data from ADVANCED-2 trial in non-muscle invasive bladder cancer (NMIBC); TARA-002 demonstrated 68% complete response rate at six months in BCG-Unresponsive patients Company expects to complete enrollment of the BCG-Unresponsive registrational cohort of the ADVANCED-2 trial in 2H 2026 On track to initiate the ADVANCED-3 registrational trial in BCG-Naïve patients in 2H 2026 Received Breakthrough Therapy and Fast Track designations for TARA-002 in lymphatic malformations (LMs); regulatory update expected in 1H 2026 Expect to report interim results from THRIVE-3 registrational trial of IV Choline Chloride in patients dependent on long-term parenteral support in 2H 2026 Completed oversubscribed $86 million public offering with participation from new and existing investors Cash, cash equivalents and investments of approximately $198 million as of December 31, 2025, expected to support planned operations into 2028 NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage biotechnology company developing transformative therapies for the treatment of cancer and rare diseases, today provided a business update and announced financial results for the fourth quarter and full year ended December 31, 2025. “Over the last few months, we reported meaningful clinical and regulatory progress across our portfolio of late-stage programs and are building on this momentum as we advance toward several important milestones in 2026,” said Jesse Shefferman, Chief Executive Officer of Protara Therapeutics. “For TARA-002 in non-muscle invasive bladder cancer (NMIBC), the clinical dataset continues to support its potential as a differentiated intravesical therapy with compelling efficacy, a favorable safety profile and a streamlined approach to administration in the clinical setting for both Bacillus Calmette-Guérin (BCG)-Unresponsive and BCG-Naïve patients. We remain on track to complete enrollment in our BCG-Unresponsive registra...

SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a company update. Company Highlights The IMG-007 Phase 2b ADAPTIVE trial in adults with moderate-to-severe atopic dermatitis (AD) is ongoing at North American sites; the study began enrolling in mid-2025 with topline data expected in 2027. A recent blinded safety review showed a favorable emerging tolerability profile consistent with previous IMG-007 patient experience. The Company has submitted a protocol amendment intended to expand the number and exposure range of dosing regimens being evaluated, characterize the role of loading doses, evaluate patient-friendly dosing intervals, and understand the effect of short- and longer-term treatment with IMG-007. The Company welcomed Dr. Ben Porter-Brown, who brings deep inflammation and medical dermatology experience including leading the development of anti-OX40L investigational therapeutic amlitelimab through the end of Phase 2, as Chief Medical Officer in February 2026. An oral presentation of IMG-007 preclinical data, including characterization of the non-depleting nature of the antibody, will be shared at the 83rd Annual Society for Investigative Dermatology (SID) Meeting (May 2026; Chicago, IL). “IMG-007 is now the leading receptor-targeting OX40 antagonist program in clinical development. Our approach is entirely unlike that of ADCC-enhanced anti-OX40 antibodies such as rocatinlimab: published data has shown rocatinlimab treatment causes deep depletion of T cells, while IMG-007 is a non-T cell depleting antibody. This is a fundamental, intentional, and critical difference in our molecule’s design,” commented Kristin Yarema, PhD, Chief Executive Officer of Imagene. “While the clinical profile of IMG-007 remains early, our safety database continues to grow and we have not seen any of the tolerability issues...

Record full-year total revenue and AVISE® CTD average selling price New biomarkers and sales force expansion drove over 11% full-year test volume growth CARLSBAD, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today reported financial results for the fourth quarter and full year ended December 31, 2025, and recent business highlights. Three Months Ended December 31, Year Ended December 31, 2025 2025 (in thousands, except ASP data) Revenue $ 16,631 $ 66,575 Gross margin 55.4 % 58.3 % Operating expenses $ 14,181 $ 52,869 Loss from operations $ (4,975 ) $ (14,070 ) Net loss $ (4,673 ) $ (19,951 ) Adjusted EBITDA $ (3,670 ) $ (9,794 ) Cash, cash equivalents and restricted cash $32,420 Trailing-twelve-month average selling price (ASP) $441 2025 Highlights: Supported the diagnosis and management of care for over 137,000 patients tested by AVISE CTD. Delivered record total revenue of $66.6 million, an increase of 20% compared to 2024. Grew AVISE CTD test volume over 11% compared to 2024. Expanded AVISE CTD trailing twelve-month ASP to $441 per test, an increase of $30 per test, or 7% compared to 2024. Enhanced the AVISE CTD platform with commercial launch of novel T-Cell and seronegative RA biomarkers, including anti-RA33 and anti-PAD4. Enriched leadership team through appointment of Michael Mahler, PhD, as Chief Scientific Officer and expanded the Board of Directors with appointment of Chas McKhann. Positioned balance sheet to support Company's path to cash flow positivity through $20 million public offering of common stock and $25 million credit facility, ending the year with $32 million in cash and cash equivalents. “Exagen is committed to improving care for autoimmune disease, delivering clarity for patients and confidence for clinicians,” said John Aballi, President and CEO. “I’m incredibly proud of our team’s accomplishments throughout 2025. Their disciplined execution advanced our operational turnaroun...

COLUMBUS, Ohio, March 10, 2026 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building products, industrial and utilities, medium and heavy-duty truck and powersports industries across the United States, Canada and Mexico today reported financial and operating results for the fiscal periods ended December 31, 2025. David Duvall, the Company’s President and Chief Executive Officer, said, “Fiscal 2025 was intensely focused on our Invest For Growth Must Win Battle – and we delivered as stated. We won $63 million in business, the majority of which was new business for Core, and over 65% of these new wins are outside our largest end markets, Truck and Powersports. We also launched proprietary sheet molding compound (SMC) into Building Products, generating close to $10 million in revenue in a large, growing addressable market. While continuing to invest for growth in 2025, we maintained disciplined operational management. We systematically improved execution through optimizing our footprint, while implementing strategies to stabilize margins, generate operating cash flow, and prepare for growth.” “In fiscal 2026, our focus is on execution: expanding the Matamoros facility and bringing the planned Monterrey plant online—on time and on budget. These projects are supported by current business, with a pipeline expected to deliver $150 million in incremental revenue over the next several years. With improving end-market visibility in the current year, we see a clear path to over $300 million in revenue in 2027.” Alex Panda, the Company’s EVP and Chief Financial Officer, commented, “As expected, fiscal 2025 revenues declined 9.5%, primarily due to weakness in the Truck sector, which represents 44% of Core’s product sales. Gross margins of 17.4%, within our previously communicated range, reflected stability despite...

Accident Year 2025 Underwriting Profitability Improves Across Every Quarter; Current Accident Year Combined Ratio Excluding California Wildfires Reaches 92.2% WILMINGTON, Del., March 10, 2026 (GLOBE NEWSWIRE) -- Global Indemnity Group, LLC (Nasdaq: GBLI) (the "Company") today reported financial results for the twelve months ended December 31, 2025. The year was defined by two distinct narratives: a significant California Wildfire loss event in January 2025, and a steady, quarter-by-quarter improvement in underlying underwriting performance that continued through year end. Net losses from the California Wildfires totaled $15.7 million pre-tax ($12.0 million after-tax). Excluding this event, the Company's current accident year combined ratio improved in each successive period throughout 2025, reaching 92.2% for the full year compared to 95.4% in 2024.This improvement drove a 17.5% increase in Pretax Adjusted Operating Contribution to $95.4 million in 2025 from $81.2 million in 2024 and contributed to a higher Adjusted Return on Equity of 14.7% in 2025 compared to 12.7% in 2024. Highlights of Consolidated Results for the Twelve Months Ended December 31, 2025 Operating Performance (Excluding California Wildfires) The current accident year combined ratio excluding California Wildfires improved in each period throughout 2025, reaching 92.2% for the full year compared to 95.4% in 2024 — an improvement of 3.2 points. The progression was: 94.8% for 1 st quarter, 94.7% for 1 st half, 93.2% for 1 st nine months, and 92.2% for the full year. compared to 95.4% in 2024 — an improvement of 3.2 points. The progression was: 94.8% for 1 quarter, 94.7% for 1 half, 93.2% for 1 nine months, and 92.2% for the full year. Current accident year underwriting income excluding California Wildfires reached $32.7 million for the full year , compared to $18.8 million in 2024. This measure improved every period throughout 2025: Flat for the 1 st quarter, +25% at for 1 st half, +38% at nine months ...

HOUSTON and LONDON, March 10, 2026 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), a leader in the global chemical industry, today announced that Agustin Izquierdo, executive vice president and chief financial officer, will participate in a fireside chat at the 2026 J.P. Morgan Industrials Conference in Washington, D.C., on Tuesday, March 17, 2026, at 3:40 p.m. EDT. Webcast and Presentation Slides Access A live webcast can be accessed at the time of the event at https://investors.lyondellbasell.com/events-and-presentations/default.aspx. A replay of the event will be available at the same link within 24 hours following the webcast. About LyondellBasell We are LyondellBasell (NYSE: LYB) – a leader in the global chemical industry creating solutions for everyday sustainable living. Through advanced technology and focused investments, we are enabling a circular and low carbon economy. Across all we do, we aim to unlock value for our customers, investors and society. As one of the world's largest producers of polymers and a leader in polyolefin technologies, we develop, manufacture and market high-quality and innovative products for applications ranging from sustainable transportation and food safety to clean water and quality healthcare. For more information, please visit www.lyondellbasell.com or follow @LyondellBasell on LinkedIn.

Applied Materials, Inc. Companies to work together at Applied’s EPIC Center in Silicon Valley to accelerate development of advanced DRAM, high-bandwidth memory and NAND storage for future AI applications Joint R&D efforts to leverage engineering teams across California and Idaho to strengthen U.S. leadership in semiconductor innovation SANTA CLARA, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced it is working with Micron Technology to develop next-generation DRAM, high-bandwidth memory (HBM) and NAND solutions that increase the energy-efficient performance of AI systems, bringing together advanced R&D capabilities from Applied’s EPIC Center in Silicon Valley and Micron’s state-of-the-art innovation center in Boise, Idaho to strengthen the semiconductor innovation pipeline in the United States. “Applied Materials and Micron have a long-standing partnership focused on driving higher performance and more energy-efficient advanced memory chips by pushing the boundaries of materials engineering and manufacturing innovation,” said Gary Dickerson, President and CEO of Applied Materials. “We are excited to deepen our collaboration with Micron as a founding partner at the EPIC Center as next-generation memory technologies play an increasingly vital role in the future of AI systems.” “Memory and storage are essential enablers of AI, and sustained innovation in these technologies is critical to unlocking AI’s full potential,” said Sanjay Mehrotra, Chairman, President and CEO of Micron Technology. “Micron has collaborated with Applied Materials for decades to deliver materials engineering innovations for new memory and storage devices, and we are pleased to extend this partnership to Applied’s new EPIC Center in Silicon Valley. Combined with Micron’s U.S.-based R&D and manufacturing hubs, this partnership creates a unique lab-to-fab pipeline to advance American memory innovation.” Teams from Applied Materials and Micron are collaborating on th...

Shirofune Shirofune ensures that no one needs to be glued to the ad management screen during peak sales events - the new feature increases sales with real-time automatic optimization EL SEGUNDO, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- Shirofune Inc. today announced the launch of a new feature within its advertising operations automation platform designed to automatically optimize Amazon advertising performance during major sales events such as Amazon’s Prime Days or Cyber Mondays. High-traffic sales periods and limited-time promotions typically bring sharp increases in demand, intensified bidding competition, and significant fluctuations in search volume and cost per click. While these events offer major revenue opportunities for advertisers and brands, they also require constant monitoring and rapid bid adjustments to stay within budget or maintain target return on ad spend (ROAS). “Sales events are moments when advertising performance can change dramatically from hour to hour, but they’ve traditionally required marketers to be constantly on standby to react,” said Mitsunaga Kikuchi, Founder and CEO of Shirofune. “With this release, we’re enabling advertisers to set clear business goals for sale days and trust the system to make precise, real-time adjustments automatically—improving both results and the sustainability of ad operations.” Shirofune’s new feature automates these operational adjustments by continuously monitoring cost progression and performance on an hourly basis throughout a specified sales day. Advertisers can choose to automatically maximize sales within a defined budget or maximize sales while maintaining a target ROAS, without the need for manual intervention. Until now, advertisers often needed to monitor campaigns continuously—from midnight through the end of a sale period, including weekends and holidays—to manually adjust bids based on real-time performance in order to avoid overspending or reduced profitability. By executing fine-grained ...

Swedish legal artificial intelligence startup Legora has raised $550 million in a Series D funding round led by Accel , tripling its valuation from an October round to $5.55 billion as it seeks to expand in the US. Existing investors Benchmark, Bessemer Venture Partners , General Catalyst , Iconiq , Redpoint Ventures and Y Combinator participated in the round, the company said in a statement Tuesday, confirming an earlier Bloomberg News report . Legal AI startups have boomed as tools powered by large language models promise to upend the profession, saving lawyers time on grunt work like document review and drafting contracts. In February, Anthropic released a plug-in to help automate legal work that sent shares of traditional legal news, software and data services companies tumbling. Legora has more than doubled its sales in every quarter since the final three months of 2024, Chief Executive Officer Max Junestrand said in an interview, declining to comment further on revenue. It plans to use the funding to rapidly grow in the US, the home market of its competitor Harvey. Legora recently announced new offices in Houston and Chicago, in addition to its existing New York and Denver hubs, and expects to have 300 employees in the US by the end of 2026. “We haven’t spent any of the money from our Series C yet,” Junestrand said. “But we’re expecting to significantly go up in our burn rate this year as we scale out the team in the US.” Harvey, which had a financing round in December, is in talks to raise funds at an $11 billion valuation, Forbes reported last month. Legora uses a mix of large language models, primarily Anthropic’s Claude, and is embedded in tools like Microsoft Word to help users analyze large volumes of documents, conduct research across databases and draft contracts. It counts major law firms including White & Case, Linklaters and Dentons as customers. With the latest round, Accel investor Arun Mathew is joining the company board. Mathew, who also co-led ...

Intermodal freight remains a vital but cyclical component of US supply chains, even as prolonged softness in trucking and rail markets pressures margins and balance sheets. In this Talking Transports podcast, STG Logistics CEO Geoff Anderman joins Bloomberg Intelligence’s Lee Klaskow to discuss the company’s proactive Chapter 11 restructuring and strategy to strengthen its financial foundation amid one of the longest freight downturns in recent history. Anderman details how STG’s asset-based int

Resale is evolving from a fragmented, thrift-driven experience into a technology-enabled infrastructure layer for the apparel industry. James Reinhart, co-founder and CEO of ThredUp, joins Bloomberg Intelligence senior equity retail analyst Poonam Goyal on this episode of the Tech Disruptors podcast. They discuss how automation, machine learning and AI are reshaping the economics of secondhand retail. He explains the “single-SKU” challenge that makes resale fundamentally different from tradition

New research reveals that the B2B customer journey takes 272 days and continues to move outside the realm of the sales department NEW YORK and COPENHAGEN, Denmark, March 10, 2026 /PRNewswire/ -- Dreamdata today released its LinkedIn Benchmarks Report 2026, revealing that LinkedIn stands alone among major advertising platforms in delivering positive returns for B2B marketers. According to the report, LinkedIn is the only platform to deliver positive return on ad spend (ROAS) at 121%, outperforming Google Search (67%) and Meta (51%) on revenue impact. This performance has driven LinkedIn to capture 41% of B2B paid social budgets, making it the single largest ad investment among platforms. LinkedIn is the only platform to deliver positive return on ad spend (ROAS) at 121% The report also reveals a fundamental shift in B2B buying behavior: the nurturing phase has become the longest and most influential part of the customer journey. B2B marketers now own 81% of the full buyer journey, which has extended from 211 days to 272 days. Notably, buyers spend the first 220 days, roughly seven months, forming their purchasing decisions through content consumption and self-education before ever entering the sales pipeline. The Dreamdata LinkedIn Ads Benchmarks Report analyzes aggregated campaign data from thousands of B2B companies, covering over 66 million sessions across 3.5 million customer journeys. This second annual report tracks year-over-year shifts in budget allocation, ROAS performance, and customer journey evolution across major advertising platforms, providing B2B marketers with reliable benchmarks to assess their strategies and demonstrate marketing's revenue impact. The year-over-year data reveals mounting complexity in B2B buying behavior. The typical buyer journey now includes 88 touchpoints (up from 76), spans 4 channels (up from 3.7) and involves 10 stakeholders (up from 6.8), indicating that B2B purchasing has become increasingly distributed, multi-channel, and ...

Applied Materials, Inc. Companies to work together at Applied’s EPIC Center in Silicon Valley to accelerate development of advanced DRAM, high-bandwidth memory and NAND storage for future AI applications Joint R&D efforts to leverage engineering teams across California and Idaho to strengthen U.S. leadership in semiconductor innovation SANTA CLARA, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced it is working with Micron Technology to develop next-generation DRAM, high-bandwidth memory (HBM) and NAND solutions that increase the energy-efficient performance of AI systems, bringing together advanced R&D capabilities from Applied’s EPIC Center in Silicon Valley and Micron’s state-of-the-art innovation center in Boise, Idaho to strengthen the semiconductor innovation pipeline in the United States. “Applied Materials and Micron have a long-standing partnership focused on driving higher performance and more energy-efficient advanced memory chips by pushing the boundaries of materials engineering and manufacturing innovation,” said Gary Dickerson, President and CEO of Applied Materials. “We are excited to deepen our collaboration with Micron as a founding partner at the EPIC Center as next-generation memory technologies play an increasingly vital role in the future of AI systems.” “Memory and storage are essential enablers of AI, and sustained innovation in these technologies is critical to unlocking AI’s full potential,” said Sanjay Mehrotra, Chairman, President and CEO of Micron Technology. “Micron has collaborated with Applied Materials for decades to deliver materials engineering innovations for new memory and storage devices, and we are pleased to extend this partnership to Applied’s new EPIC Center in Silicon Valley. Combined with Micron’s U.S.-based R&D and manufacturing hubs, this partnership creates a unique lab-to-fab pipeline to advance American memory innovation.” Teams from Applied Materials and Micron are collaborating on th...

Hand Arendall Harrison Sale Transforms Document Workflows and Sees Immediate ROI with Litera's AI-Powered Drafting and Compare Customer results highlight growing demand for unified drafting, comparison, and collaboration within Microsoft 365 and web NEW YORK, March 10, 2026--(BUSINESS WIRE)--Legalweek 2026--Litera, a global leader in legal AI technology solutions, shared new customer results at Legalweek demonstrating how law firms are transforming document workflows and realizing immediate value with Litera’s AI-powered drafting and compare. Hand Arendall Harrison Sale, one of the largest law firms in the Southeastern U.S. with more than 85 lawyers across Alabama and Florida, recently deployed Litera One as part of a broader technology modernization initiative. By unifying drafting, comparison, and collaboration directly within Microsoft 365 and extending workflows to web and mobile, the firm streamlined document processes and eliminated long-standing friction for attorneys. "Litera One just runs circles around Word, and the Outlook integration is a game-changer," said Deborah Savadra, Application Support Specialist & Trainer at Hand Arendall Harrison Sale. "Having Litera One directly within Word and Outlook makes the user experience seamless, and the iManage integration removes friction so that the DMS remains our source of truth for client matter documents." Prior to implementation, document comparison tools were creating friction among some of the firm's most experienced users. After adopting Litera One's drafting capabilities, the firm recorded zero complaints and just a single Help Desk call following rollout, signaling immediate user adoption and measurable operational impact. The results reflect a broader shift across the legal industry as firms move toward unified, embedded workflows that reduce context-switching and accelerate time to value. Litera One brings together the tools attorneys rely on every day – drafting, review, knowledge, and performance work...

Applied Materials, Inc. Companies to work together at Applied’s EPIC Center in Silicon Valley to accelerate development of advanced DRAM, high-bandwidth memory and NAND storage for future AI applications Joint R&D efforts to leverage engineering teams across California and Idaho to strengthen U.S. leadership in semiconductor innovation SANTA CLARA, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced it is working with Micron Technology to develop next-generation DRAM, high-bandwidth memory (HBM) and NAND solutions that increase the energy-efficient performance of AI systems, bringing together advanced R&D capabilities from Applied’s EPIC Center in Silicon Valley and Micron’s state-of-the-art innovation center in Boise, Idaho to strengthen the semiconductor innovation pipeline in the United States. “Applied Materials and Micron have a long-standing partnership focused on driving higher performance and more energy-efficient advanced memory chips by pushing the boundaries of materials engineering and manufacturing innovation,” said Gary Dickerson, President and CEO of Applied Materials. “We are excited to deepen our collaboration with Micron as a founding partner at the EPIC Center as next-generation memory technologies play an increasingly vital role in the future of AI systems.” “Memory and storage are essential enablers of AI, and sustained innovation in these technologies is critical to unlocking AI’s full potential,” said Sanjay Mehrotra, Chairman, President and CEO of Micron Technology. “Micron has collaborated with Applied Materials for decades to deliver materials engineering innovations for new memory and storage devices, and we are pleased to extend this partnership to Applied’s new EPIC Center in Silicon Valley. Combined with Micron’s U.S.-based R&D and manufacturing hubs, this partnership creates a unique lab-to-fab pipeline to advance American memory innovation.” Teams from Applied Materials and Micron are collaborating on th...

TSMC February 2026 Revenue Report Taiwan Semiconductor

Beyond Air ( XAIR ) has terminated an agreement with XTL Biopharmaceuticals to sell its majority ownership interest in NeuroNOS subsidiary The companies had entered into a letter of intent in January 2026. The letter of intent expired on March 9, 2026, in accordance with its terms, and the parties did not enter into a definitive agreement. XAIR +4.40% premarket to $0.8968. Source: Press Release More on Beyond Air Beyond Air Q3 2026 Earnings Preview Beyond Air appoints Dan Moorhead as CFO Seeking Alpha’s Quant Rating on Beyond Air Historical earnings data for Beyond Air

(RTTNews) - CRISPR Therapeutics AG (CRSP), on Tuesday said it intends to offer $350 million aggregate principal amount of convertible senior notes due 2031 in a private placement. The company said that the initial purchasers will have a 13-day option to buy up to an additional $52.5 million aggregate principal amount of the notes. The notes will be senior unsecured obligations and will mature on March 1, 2031, unless earlier converted, redeemed, or repurchased. Interest will be payable semiannually on March 1 and September 1 each year beginning September 1. The company intends to use the net proceeds from the offering for general corporate purposes. In the pre-market trading, CRSP is 8.23% lesser at $53.94 on the Nasdaq. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

(RTTNews) - The UK stock market remains high up in positive territory on Tuesday, recovering from three successive days of losses, with a sharp drop in oil prices help easing concerns about inflation and prompting investors to indulge in some brisk buying. U.S. President Donald Trump's remarks that the war in the Middle East could come to a quick end contributed as well to the improved sentiment in the market. Shares from mining, banking and aviation sectors, which had taken a beating in recent sessions, are among the notable gainers. Realty stocks are up as well. Energy stocks are down, weighed down by weak oil prices. The benchmark FTSE 100, which climbed to 10,443.20, was up 149.63 points or 1.46% at 10,399.15 nearly an hour past noon. Pershing Square Holdings is rising 7.5%. Persimmon is up 6.75% after reporting higher sales and profits for the full year. Bank stocks Barclays, Standard Chartered and Lloyds Banking Group are up 4.75%, 4% and 3.75%, respectively. HSBC Holdings and Natwest Group are gaining 2.8% and 2.7%, respectively. IAG is climbing up 5.3% and Easyjet is rising 2.7%. Miners Anglo American Plc, Fresnillo and Antofagasta are up 4%-5%. Glencore is advancing 2.75%. Rolls-Royce Holding, St. James's Place, Spirax Group, Hikma Pharmaceuticals, Segro, Games Workshop, Aviva, Legal & General, Standard Life, Halma, M&G, JD Sports Fashion, Intercontiental Hotels Group, Admiral Group and Weir Group are up 3%-5%. Energy stocks BP and Shell are down 2.7% and 1.5%, respectively. Data from British Retail Consortium showed UK retail sales rose 0.7% year-on-year on a like-for-like basis in February 2026, falling short of market expectations for a 2.4%. Retail sales rose 2.3% in January. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

记者获悉，中国证券业协会近日在行业内开展了2025年度证券行业人力资源管理情况调研，旨在全面扫描行业人力资源管理现状，为推动行业人才队伍建设、助力高质量发展提供决策参考。据悉，此次调研包括证券公司（399975）人力资源管理整体情况调研和组织架构管理专项调研两个部分，调研结果将用于编写《2025年证券行业人力资源管理发展综述》，成为未来政策制定与证券公司（399975）战略调整的重要依据。各证券公司（399975）须在3月13日前完成问卷填报。(中证金牛座)

上周逝世的中共元老宋平，遺體今日在北京火化。 儀式上午在八寶山革命公墓舉行，宋平遺體以中國共產黨黨旗覆蓋，形容他是優秀黨員。中共總書記習近平等領導人到場送別，前總書記胡錦濤亦有致送花圈。 新華社報道指，宋平病重期間，習近平、李強等現任領導人，及胡錦濤等前領導人，前往醫院或透過各種形式探望，對他的離世表示沉痛哀悼，並向其親屬深切慰問。 1917年出生的宋平，曾擔任周恩來政治秘書、國務委員、國家計劃委員會主任。1989年出任中共中央政治局常委，1992年卸任。在本月4日因病醫治無效，在北京離世，享年109歲。

文章提及标的 金海通 -- 金海通（603061）公告，2025年营业收入6.98亿元，同比增长71.68%。净利润1.77亿元，同比增长124.93%。公司拟向全体股东每股派发现金红利0.38元(含税)，以资本公积转增股本方式向全体股东每10股转增4.5股。

Solskin/DigitalVision via Getty Images Thesis Agilent Technologies ( A ) has just announced the acquisition of Biocare Medical. And while the stock price hasn't reacted that much, I feel Biocare's current portfolio should come as a big help in terms of expanding Agilent’s presence in high-growth pathology and cancer diagnostics. It should also increase its exposure to higher-margin consumables and recurring revenue streams later on. Management has also guided to mid-single-digit revenue growth with high-single-digit to low-double-digit EPS growth. As of now, Agilent looks set to remain a pretty stable compounder within the life sciences tools sector. And given the fact that the stock currently trades below its own historical valuation multiples, the investment for me here mainly hinges on executing that strategy of expanding diagnostics capabilities. The next stop would then be taking advantage of their global distribution network to scale Biocare's offerings in other geographies. Now, this may take some time, but eventually the bull case here is that Agilent shift their revenue mix toward higher-margin consumables and services. 1Q26 financials Back in late February, Agilent reported 1Q26 results, and I thought they delivered a pretty strong start to the year. 1Q26 revenue managed to hit $1.80 billion, which was about 7.0% year-over-year growth on a reported basis and just 4.4% growth on a core basis, so the latter here would exclude currency fluctuations and acquisitions. The performance also showed a pretty steady demand for analytical/laboratory technologies. Revenue was mainly driven by their strength in services and replacement cycles for laboratory instruments. However, GAAP net income actually declined slightly to just $305 million or about $1.07 per share compared with the $318 million and $1.11 per share we saw back a year ago. I think we can put this decrease down to some higher operating costs and restructuring-related adjustments, as when you exclude cer...

为提升公司治理结构，三星电子和SK公司周二宣布，将共同取消总计20.8万亿韩元（约合141亿美元）的库存股。这一举措成为韩国企业中最大规模的库存股注销之一，标志着韩国企业在响应公司治理改革方面迈出了重要步伐。 两家公司表示，此次取消库存股旨在提升股东回报，缩小“韩国折扣”——即韩国股票相对于全球同行的估值差距。长期以来，这一折扣与韩国企业的治理问题密切相关，已成为全球投资者关切的焦点。 三星电子将在今年上半年取消8700万股库存股，包括优先股。与此同时，SK公司计划注销约4.8万亿韩元的库存股，占其流通股本的20%。这些举措符合韩国推动公司治理改革的整体趋势，并响应去年通过的《商业法》修订，要求企业取消库存股，从而减少将库存股作为控制机制的做法，转而注重提升股东价值。 韩国股市表现强劲，Kospi指数成为全球表现最好的主要股指之一，部分原因归功于市场对公司治理改革的期望。 三星与SK的最新公告被视为韩国企业治理改革取得进展的重要信号。 通过减少流通股数量，两家公司旨在提高每股收益和股东权益回报率，这些都是全球投资者密切关注的关键指标。此次改革不仅符合新修订的《商业法》，也反映了公司提升股东价值的意图。 投资者对这一改革措施表示欢迎。近期，未来资产人寿保险公司宣布取消库存股后，股价上涨了30%，而SK证券公司也因股票合并而股价上涨了17%。 随着韩国进入年度股东大会季节，预计将于3月达到高峰。今年的股东大会将检验新的公司治理机制的有效性，机构投资者和代理顾问将更加关注董事会独立性、股东回报政策以及资本配置等议题，标志着韩国企业治理结构的重大转型。 风险提示及免责条款 市场有风险，投资需谨慎。本文不构成个人投资建议，也未考虑到个别用户特殊的投资目标、财务状况或需要。用户应考虑本文中的任何意见、观点或结论是否符合其特定状况。据此投资，责任自负。

.Alaris Equity Partners Income Trust press release ( AD.UN:CA ): Q4 earnings and comprehensive income was a loss of $0.2 million Revenue of $30.91M (+15.9% Y/Y) misses by $14.64M . Total Partner revenue for Q1 2026 is expected to be approximately $46.9 million, reflecting seasonal distribution timing, recent investment activity and a 4% preferred distribution reset increase in distributions eligible for reset in 2025. More on Alaris Equity Partners Income Trust Seeking Alpha’s Quant Rating on Alaris Equity Partners Income Trust Historical earnings data for Alaris Equity Partners Income Trust Dividend scorecard for Alaris Equity Partners Income Trust Financial information for Alaris Equity Partners Income Trust

內地近期興起「養龍蝦」熱潮，所指的是一款人工智能軟件，可以協助用戶處理文書等工作，非常受「打工仔」歡迎。不過專家提醒，不應依賴科技，代人類做決策。 剛過去的周末，騰訊在深圳舉辦免費安裝人工智能AI軟件OpenClaw的服務，吸引近千人參加。 OpenClaw是一款由奧地利軟件工程師開發的開源AI智能體工具，因為程式標誌是一隻紅色龍蝦，所以被內地用家稱為「龍蝦」。相對其他一問一答的AI工具，「龍蝦」具有學習及行動功能，經訓練後，可直接幫助用戶操作事務，例如寫報告、收發郵件、自動修復程式問題等。這個訓練過程，則被稱為「養龍蝦」。 有深圳法律顧問公司稱，引入OpenClaw後，處理法律文件的效率較以往提升六成，亦有不少「打工仔」靠它來幫輕工作。 有內地市民表示：「最直觀的感受就是，『龍蝦』相比我原來用的一些大模型，它可能就不僅僅去給你輸出一些東西，它可以直接去幫我完成一些實際的任務，我覺得它就是一個每天都在進步的真實員工。」 在內地，有人提供「龍蝦」上門安裝服務，根據不同需求，收費由數百至數千元人民幣不等。 有中國科學院院士指出，雖然建議大眾使用新技術，但仍要保持風險意識。 中國科學院院士郭雷指：「還是要理解它，目前來講還只是個工具，還不能完全用它來取代人的決策，目前來講還是有風險的。」 而工信部稱，日前監測發現OpenClaw在使用時，信任邊界模糊，而且具備自主決策等特性，可能在被惡意接管等情況下，造成資訊洩漏等安全風險。

《科创板日报》3月10日讯（记者 李明明） “养龙虾”潮持续席卷。 3月10日，智谱AI正式上线AutoClaw（中文名：澳龙），支持用户一键安装的本地版OpenClaw应用，将此前高门槛的AI智能体部署，简化为普通软件的“下载-安装-打开”三步操作，降低现象级开源项目OpenClaw的普及门槛。 这个产品的出现，一定程度也回应了一个在过去几个月困扰无数AI玩家的问题：想用OpenClaw，究竟要跨过多少门槛？ 关于OpenClaw未来走向何方，赛迪顾问人工智能与大数据研究中心分析师白润轩对《科创板日报》记者分析， OpenClaw 接下来会从火爆走向更务实、更安全的发展阶段。 实测智谱AutoClaw 《科创板日报》记者上手体验了智谱的AutoClaw，大约1分钟将 OpenClaw 安装到本地电脑。最直观的感受就是门槛较低，下载到部署全程都像操作普通手机App一样简单，非技术背景也能较为轻松完成。 《科创板日报》记者输入指令：用户指令：我想做一个深度调研，方向是：GLM-5 coding & agent能力。请帮我：1. 从多个角度拆解这个问题；2. 搜索中英文信源，交叉验证数据；3. 给出结构清晰、有数据支撑、有独立洞察的深度报告。 几分钟后，智谱生成了比较完备的深度报告。 据智谱相关负责人对《科创板日报》记者介绍，AutoClaw特色就在低门槛，无需用户了解API key及进行相关配置，付费逻辑改为积分制而非按token计费，打破技术壁垒，面向非程序员、非极客群体。 他进一步表示，AutoClaw相关产品有网页端、客户端两种形态，团队在1月份已基于AutoGLM跟进上线了相关网页版产品。 相较于同类竞品的核心优势上，他认为，AutoClaw搭载了智谱全新的Pony-Alpha-2模型，该模型在OpenClaw场景能力上提升显著。结合AutoGLM底层能力，可进一步提升AutoClaw的能力上限。 普通用户“养龙虾”卡在了“第一步” 近月，开源AI智能体OpenClaw（龙虾）风靡全球，国内“养龙虾”火爆，从极客圈破圈至普通用户群体。 但狂欢背后，是绝大多数普通用户的“入门即放弃”。 OpenClaw原生部署对非技术用户门槛高，要么月租数百元租云服务器，要么需手动配置本地环境、调试专业参数，不少用户因依赖报错难以搞定；这还催生了“代装龙虾”产业链，各平台代装服...

Our cartoonist reflects on the FA Cup fifth round, including Ben Waine’s commitment to the bit Buy a cartoon | David’s favourite works of 2025 And his latest book, Chaos in the Box: get it now Continue reading...

Analysts Are Bullish on Top Technology Stocks: Broadcom (AVGO), Rubrik, Inc. Class A (RBRK) The Globe and Mail

內地宣布，因應國際局勢上調油價，加幅是四年來最大。 周一傍晚，上海不少車主趕於加價前到油站入油，油站外一度出現車龍。四川成都這個油站，情況亦差不多。 根據國內成品油調價機制，內地汽油及柴油價格由周二凌晨零時起，每噸分別上調695元及670元人民幣，是2022年3月以來最大升幅。新油價下，汽油價格每公升為7.63元至8.14元人民幣，但加價後仍只是香港約四分之一的價錢。至於柴油每公升，為7.27元人民幣。 據估算，內地駕駛人士如要入滿一缸50升的油，要較加價前多付約30元人民幣。